Innovate Oncology, Inc. (the "Company" or "Innovate") acquires, develops and seeks to commercialize novel compounds to treat various types of cancer. The Company's portfolio of compounds under development consists of three compounds that are being tested to target some of the most common types of cancer, such as breast cancer, which is the second most prevalent type worldwide, according to the World Health Organization, as well as some of the most lethal, such as pancreatic cancer, in which the five-year survival rate is only about 4.4%, according to the American Cancer Society.
The Company is an indirect subsidiary of Bioaccelerate Holdings, Inc....
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
